News
Media
Conference
Publication
CME/CE
Partners
Resources
Contribute
Subscribe
Clinical Forum Insights

Advances in the Treatment Landscape for HIV

EP. 1: Burden of HIV in the USA and Associated Symptoms

March 27th 2020

EP. 2: Screening Recommendations for HIV and Risk Stratification

March 27th 2020

EP. 3: PrEP Therapy for High-Risk HIV Candidates

March 27th 2020

EP. 4: Safety Profiles of FDA-Approved PrEP Agents

March 27th 2020

EP. 5: State Medicaid Reimbursement for Routine HIV Screening

March 27th 2020

EP. 6: Rapid Initiation of HIV Treatment With ART

March 27th 2020

EP. 7: Factors Considered in Choosing Initial HIV Therapeutic Regimen

March 27th 2020

EP. 8: Safety Profile and Costs of Initial HIV Therapeutic Regimen

March 27th 2020

EP. 9: Switching Therapies in Patients Who Are Successfully Treated

March 27th 2020

EP. 10: Virological Failure or Rebound to HIV Therapies

March 27th 2020

EP. 11: Emerging Treatment Options for HIV

March 27th 2020

EP. 12: Drug Resistance or Intolerance to HIV Therapy

March 27th 2020

EP. 13: Long-Acting Injectables to Treat HIV

March 27th 2020

EP. 14: Long-Acting Injectables as PrEP Therapy

March 27th 2020

Trending on Contagion Live

Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus

Measles Update: February 6, 2026

PASTEUR Act Reintroduced in Congress

Antibiotics Deconstructed: IV Fosfomycin

HIV Spending for Fiscal Year 2026: The Latest Update